Steven D. Ertel
2015
In 2015, Steven D. Ertel earned a total compensation of $4.3M as Executive Vice President and Chief Operating Officer at Acceleron Pharma, a 841% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $158,911 |
|---|---|
| Option Awards | $1,783,327 |
| Salary | $404,107 |
| Stock Awards | $1,927,580 |
| Other | $5,000 |
| Total | $4,278,925 |
Ertel received $1.9M in stock awards, accounting for 45% of the total pay in 2015.
Ertel also received $158.9K in non-equity incentive plan, $1.8M in option awards, $404.1K in salary and $5K in other compensation.
Rankings
In 2015, Steven D. Ertel's compensation ranked 1,993rd out of 13,638 executives tracked by ExecPay. In other words, Ertel earned more than 85.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,993 out of 13,638 | 85th |
Division Manufacturing | 708 out of 5,190 | 86th |
Major group Chemicals And Allied Products | 256 out of 1,854 | 86th |
Industry group Drugs | 201 out of 1,528 | 87th |
Industry Biological Products, Except Diagnostic Substances | 34 out of 254 | 87th |
Source: SEC filing on April 15, 2016.
Ertel's colleagues
We found four more compensation records of executives who worked with Steven D. Ertel at Acceleron Pharma in 2015.